The global pharmaceutical company will pay LBT more than $3.4m for the five devices and ongoing support, with most of the revenue to be received in the next six months. AstraZeneca is expected to ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
LBT Innovations ( ASX:LBT ) Full Year 2023 Results Key Financial Results Revenue: AU$2.13m (flat on FY 2022). Net loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results